Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group
伊沙佐米、来那度胺和地塞米松（IRD）联合细胞遗传学风险维持治疗在适合移植的多发性骨髓瘤患者中的应用：北欧骨髓瘤研究组开展的一项II期多中心研究
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16051024
Partanen, Anu; Waage, Anders; Peceliunas, Valdas; Schjesvold, Fredrik; Anttila, Pekka; Säily, Marjaana; Uttervall, Katarina; Putkonen, Mervi; Carlson, Kristina; Haukas, Einar; Sankelo, Marja; Szatkowski, Damian; Hansson, Markus; Marttila, Anu; Svensson, Ronald; Axelsson, Per; Lauri, Birgitta; Mikkola, Maija; Karlsson, Conny; Abelsson, Johanna; Ahlstrand, Erik; Sikiö, Anu; Klimkowska, Monika; Matuzeviciene, Reda; Fenstad, Mona Hoysaeter; Ilveskero, Sorella; Pelliniemi, Tarja-Terttu; Nahi, Hareth; Silvennoinen, Raija
